Aspergillus-specific IgM/IgG antibody serostatus of patients hospitalized with moderate-critical COVID-19 in Uganda
African Health Sciences
;
22(3): 506-511, 2022-10-26. Tables
Artigo
em Inglês
| AIM
| ID: biblio-1401811
ABSTRACT
Invasive pulmonary aspergillosis is known to complicate the coronavirus diseases-2019 (COVID-19), especially those with critical illness. We investigated the baseline anti Aspergillus antibody serostatus of patients with moderate-critical COVID-19 hospitalized at 3 COVID-19 Treatment Units in Uganda. All 46 tested patients, mean age 30, and 11% with underlying respiratory disease had a negative serum anti-Aspergillus IgM/IgG antibody immunochromatographic test on day 3 (mean) of symptom onset (range 1-26), but follow up specimens to assess seroconversion were not available
Texto completo:
DisponíveL
Índice:
AIM (África)
Assunto principal:
Estado Terminal
/
Aspergilose Pulmonar Invasiva
/
COVID-19
País/Região como assunto:
África
Idioma:
Inglês
Revista:
African Health Sciences
Ano de publicação:
2022
Tipo de documento:
Artigo
Instituição/País de afiliação:
Department of Immunology and Molecular Biology, Makerere University College of Health Sciences, Kampala, Uganda/UG
/
Department of Internal Medicine, Mulago National Referral Hospital, Kampala, Uganda/UG
/
Department of Medical Microbiology and Immunology, Gulu University Medical School, Gulu Uganda/UG
/
Department of Medical Microbiology, College of Health Sciences, Makerere University, Kampala, Uganda/UG
/
Department of Pediatrics and Child Health, College of Health Sciences, Makerere University, Kampala, Uganda/UG
/
Department of Radiology and Radiotherapy, College of Health Sciences, Makerere University, Kampala, Uganda/UG
/
Makerere University Lung Institute, College of Health Sciences, Makerere University, Kampala, Uganda/UG
/
Translational research laboratory, Department of Research, Infectious Diseases Institute, College of Health Sciences, Makerere University, P.O Box 22418, Kampala, Uganda/UG
Similares
MEDLINE
...
LILACS
LIS